Takeda wins long-awaited US approval for first oral drug for eosinophilic esophagitis
The FDA on Monday approved Takeda’s Eohilia, the first oral drug for patients with eosinophilic esophagitis (EoE) in the US, which the company briefly abandoned …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
